These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
173 related articles for article (PubMed ID: 30905176)
1. Multivariate approaches for the development of quality control in-situ fiber optics dissolution methods for fixed-dose combination tablets. Medendorp J; Colón I; Ryan T Drug Dev Ind Pharm; 2019 Jun; 45(6):999-1008. PubMed ID: 30905176 [TBL] [Abstract][Full Text] [Related]
2. In-line quantification of micronized drug and excipients in tablets by near infrared (NIR) spectroscopy: Real time monitoring of tabletting process. Karande AD; Heng PW; Liew CV Int J Pharm; 2010 Aug; 396(1-2):63-74. PubMed ID: 20558264 [TBL] [Abstract][Full Text] [Related]
3. Near infrared spectroscopy to monitor drug release in-situ during dissolution tests. Sarraguça MC; Matias R; Figueiredo R; Ribeiro PR; Martins AT; Lopes JA Int J Pharm; 2016 Nov; 513(1-2):1-7. PubMed ID: 27601336 [TBL] [Abstract][Full Text] [Related]
4. Bilayer Tablet Dissolution Kinetics Based on a Degassing Cyclic Flow UV-Vis Spectroscopy with Chemometrics. Otsuka Y; Ito A; Takahashi T; Matsumura S; Takeuchi M; Tanaka H Chem Pharm Bull (Tokyo); 2019; 67(4):361-366. PubMed ID: 30930440 [TBL] [Abstract][Full Text] [Related]
5. Sustained release dosage forms dissolution behavior prediction: a study of matrix tablets using NIR spectroscopy. Tabasi SH; Moolchandani V; Fahmy R; Hoag SW Int J Pharm; 2009 Dec; 382(1-2):1-6. PubMed ID: 19660535 [TBL] [Abstract][Full Text] [Related]
6. Non-destructive determination of the coating film thickness by X-ray powder diffractometry and correlation with the dissolution behavior of film-coated tablets. Yamada H; Terada K; Suryanarayanan R J Pharm Biomed Anal; 2010 Mar; 51(4):952-7. PubMed ID: 19945243 [TBL] [Abstract][Full Text] [Related]
7. Quality control of multi-component, intact pharmaceutical tablets with three different near-infrared apparatuses. Cournoyer A; Simard JS; Cartilier L; Abatzoglou N Pharm Dev Technol; 2008; 13(5):333-43. PubMed ID: 18798121 [TBL] [Abstract][Full Text] [Related]
8. Evaluation and comparison of five matrix excipients for the controlled release of acrivastine and pseudoephedrine. Gu X; Fediuk DJ; Simons FE; Simons KJ Drug Dev Ind Pharm; 2004; 30(10):1009-17. PubMed ID: 15595567 [TBL] [Abstract][Full Text] [Related]
9. A process analytical technology approach based on near infrared spectroscopy: tablet hardness, content uniformity, and dissolution test measurements of intact tablets. Blanco M; Alcalá M; González JM; Torras E J Pharm Sci; 2006 Oct; 95(10):2137-44. PubMed ID: 16883562 [TBL] [Abstract][Full Text] [Related]
10. Enhanced dissolution of sildenafil citrate as dry foam tablets. Sawatdee S; Atipairin A; Sae Yoon A; Srichana T; Changsan N Pharm Dev Technol; 2019 Jan; 24(1):1-11. PubMed ID: 28135896 [TBL] [Abstract][Full Text] [Related]
11. Correlation of dissolution and disintegration results for an immediate-release tablet. Nickerson B; Kong A; Gerst P; Kao S J Pharm Biomed Anal; 2018 Feb; 150():333-340. PubMed ID: 29287259 [TBL] [Abstract][Full Text] [Related]
12. Interaction between fed gastric media (Ensure Plus®) and different hypromellose based caffeine controlled release tablets: comparison and mechanistic study of caffeine release in fed and fasted media versus water using the USP dissolution apparatus 3. Franek F; Holm P; Larsen F; Steffansen B Int J Pharm; 2014 Jan; 461(1-2):419-26. PubMed ID: 24342711 [TBL] [Abstract][Full Text] [Related]
13. Development and validation of an in-line NIR spectroscopic method for continuous blend potency determination in the feed frame of a tablet press. De Leersnyder F; Peeters E; Djalabi H; Vanhoorne V; Van Snick B; Hong K; Hammond S; Liu AY; Ziemons E; Vervaet C; De Beer T J Pharm Biomed Anal; 2018 Mar; 151():274-283. PubMed ID: 29413975 [TBL] [Abstract][Full Text] [Related]
14. Comprehensive validation scheme for in situ fiber optics dissolution method for pharmaceutical drug product testing. Mirza T; Liu QJ; Vivilecchia R; Joshi Y J Pharm Sci; 2009 Mar; 98(3):1086-94. PubMed ID: 18623216 [TBL] [Abstract][Full Text] [Related]
16. In silico and in vitro methods to optimize the performance of experimental gastroretentive floating mini-tablets. Eberle VA; Häring A; Schoelkopf J; Gane PA; Huwyler J; Puchkov M Drug Dev Ind Pharm; 2016; 42(5):808-17. PubMed ID: 26307090 [TBL] [Abstract][Full Text] [Related]
17. Effect of Excipients on Salt Disproportionation during Dissolution: A Novel Application of In Situ Raman Imaging. Abouselo A; Rance GA; Tres F; Taylor LS; Kwokal A; Renou L; Scurr DJ; Burley JC; Aylott JW Mol Pharm; 2021 Sep; 18(9):3247-3259. PubMed ID: 34399050 [TBL] [Abstract][Full Text] [Related]
18. Quality-by-design case study: investigation of the role of poloxamer in immediate-release tablets by experimental design and multivariate data analysis. Kaul G; Huang J; Chatlapalli R; Ghosh K; Nagi A AAPS PharmSciTech; 2011 Dec; 12(4):1064-76. PubMed ID: 21861241 [TBL] [Abstract][Full Text] [Related]
19. High-throughput NIR-chemometric methods for chemical and pharmaceutical characterization of sustained release tablets. Porfire A; Filip C; Tomuta I J Pharm Biomed Anal; 2017 May; 138():1-13. PubMed ID: 28171787 [TBL] [Abstract][Full Text] [Related]
20. In-line ATR-UV and Raman Spectroscopy for Monitoring API Dissolution Process During Liquid-Filled Soft-Gelatin Capsule Manufacturing. Wan B; Zordan CA; Lu X; McGeorge G AAPS PharmSciTech; 2016 Oct; 17(5):1173-81. PubMed ID: 26604007 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]